- Home
- NRC vs ANGO Comparison
NRC vs ANGO Comparison
Compare NRC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRC | ANGO |
|---|---|---|
| Founded | 1981 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.8M | 420.2M |
| IPO Year | 1997 | 2004 |
Fundamental Metrics
Financial Performance| Metric | NRC | ANGO |
|---|---|---|
| Price | $17.72 | $10.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 65.5K | ★ 513.0K |
| Earning Date | 05-05-2026 | 04-02-2026 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | ★ 4707.69 | 81.92 |
| EPS | ★ 50.00 | N/A |
| Revenue | $119,686,000.00 | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.51 |
| Revenue Next Year | N/A | $4.96 |
| P/E Ratio | $0.36 | ★ N/A |
| Revenue Growth | 1.81 | ★ 10.17 |
| 52 Week Low | $9.76 | $8.36 |
| 52 Week High | $22.79 | $13.99 |
Technical Indicators
Market Signals| Indicator | NRC | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 58.02 | 48.99 |
| Support Level | $16.64 | $10.38 |
| Resistance Level | $18.18 | $11.06 |
| Average True Range (ATR) | 0.75 | 0.57 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 74.85 | 42.88 |
Price Performance
Historical ComparisonAbout NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.